Cytopenia among CML Patients on Imatinib in Kenya: Types, Grades, and Time Course

Cytopenia among CML Patients on Imatinib in Kenya: Types, Grades, and Time Course

Background. Imatinib mesylate is the gold standard for the treatment of all phases of Philadelphia-positive chronic myeloid leukemia. Patients on imatinib treatment may develop cytopenia due to drug toxicity. This study aimed to determine the types, grades, and time course of cytopenia in CML patien...

Full description

Saved in:
Bibliographic Details
Main Authors: Angela McLigeyo, Jamilla Rajab, Mohammed Ezzi, Peter Oyiro, Yatich Bett, Andrew Odhiambo, Matilda Ong’ondi, Sitna Mwanzi, Mercy Gatua, NAOthieno- Abinya
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Advances in Hematology
Online Access:http://dx.doi.org/10.1155/2020/7696204
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items